参考文献/References:
[1].顾东风,黄广勇,吴锡桂,等. 中国心力衰竭流行病学调查及其患病率[J]. 中华心血管病杂志,2003,31(1):4.
[2].黄刚,邓晓奇,张小刚,等. 2020德国永久性心脏辅助装置植入者紧急医疗处置共识[J]. 心血管病学进展,2020,41(12):1353-1358.
[3].Pappone C,Vicedomini G,Salvati A,et al. Electrical modulation of cardiac contractility:clinical aspects in congestive heart failure[J]. Heart Fail Rev,2001,6(1):55-60.
[4].Cappannoli L,Scacciavillani R,Rocco E,et al. Cardiac contractility modulation for patient with refractory heart failure:an updated evidence-based review[J]. Heart Fail Rev,2021,26(2):227-235.
[5].Goliasch G,Khorsand A,Schütz M,et al. The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure[J].?Eur J Nucl Med Mol Imaging,2012,39(3):408-415.
[6].Impulse Dynamics. OPTIMIZER? Smart Implantable Pulse Generator INSTRUCTIONS FOR USE[Z/OL]. (2020-11-13)[2022-03-08].https://impulse-dynamics.com/global/wp-content/uploads/sites/2/2020/11/13-290-008-EU-OPTIMIZER-Smart-IPG-IFU-ENG-Rev-09.pdf
[7].Lawo T,Borggrefe M,Butter C,et al. Electrical signals applied during the absolute refractory period:an investigational treatment for advanced heart failure in patients with normal QRS duration[J]. J Am Coll Cardiol,2005,46(12):2229-2236.
[8].Wood EH,Heppner RL,Weidmann S. Inotropic effects of electric currents.Ⅰ. Positive and negative effects of constant electric currents or current pulses applied during cardiac action potentials.Ⅱ. Hypotheses:calcium movements,excitation-contraction coupling and inotropic effects[J]. Circ Res,1969,24(3):409-445.
[9].Bouchard RA,Clark RB,Giles WR. Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements[J]. Circ Res,1995,76(5):790-801.
[10].Mohri S,He KL,Dickstein M,et al. Cardiac contractility modulation by electric currents applied during the refractory period[J]. Am J Physiol Heart Circ Physiol,2002,282(5):H1642-H1647.
[11].Cannell MB,Kong CH. Local control in cardiac E-C coupling[J].?J Mol Cell Cardiol,2012,52(2):298-303.
[12].Brunckhorst CB,Shemer I,Mika Y,et al. Cardiac contractility modulation by non-excitatory currents:studies in isolated cardiac muscle[J]. Eur J Heart Fail,2006,8(1):7-15.
[13].Lyon AR,Samara MA,Feldman DS. Cardiac contractility modulation therapy in advanced systolic heart failure[J]. Nat Rev Cardiol,2013,10(10):584-598.
[14].Imai M,Rastogi S,Gupta RC,et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure[J].?J Am Coll Cardiol,2007,49(21):2120-2128.
[15].Feaster TK,Casciola M,Narkar A,et al. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes[J].?Physiol Rep,2021,9(21):e15085.
[16].Roubertie F,Eschalier R,Zemmoura A,et al. Cardiac contractility modulation in a model of repaired tetralogy of Fallot:a sheep model[J].?Pediatr Cardiol,2016,37(5):826-833.
[17].Tsch?pe C,Kherad B,Klein O,et al. Cardiac contractility modulation:mechanisms of action in heart failure with reduced ejection fraction and beyond[J]. Eur J Heart Fail,2019,21(1):14-22.
[18].Ning B,Zhang F,Song X,et al. Cardiac contractility modulation attenuates structural and electrical remodeling in a chronic heart failure rabbit model[J].?J Int Med Res,2020,48(10):300060520962910.
[19].Hao Q,Zhang F,Wang Y,et al. Cardiac contractility modulation attenuates chronic heart failure in a rabbit model via the PI3K/AKT pathway[J].?Biomed Res Int,2020,2020:1625362.
[20].Chen H,Liu S,Zhao C,et al. Cardiac contractility modulation improves left ventricular systolic function partially via miR-25 mediated SERCA2A expression in rabbit trans aortic constriction heart failure model [J].?J Thorac Dis,201810(6):3899-3908.
[21].Butter C,Rastogi S,Minden HH,et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure[J]. J Am Coll Cardiol,2008,51(18):1784-1789.
[22].Neelagaru SB,Sanchez JE,Lau SK,et al. Nonexcitatory,cardiac contractility modulation electrical impulses:feasibility study for advanced heart failure in patients with normal QRS duration[J]. Heart Rhythm,2006,3(10):1140-1147.
[23].Borggrefe MM,Lawo T,Butter C,et al. Randomized,double blind study of non-excitatory,cardiac contractility modulation electrical impulses for symptomatic heart failure[J]. Eur Heart J,2008,29(8):1019-1028.
[24].Kadish A,Nademanee K,Volosin K,et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure[J]. Am Heart J,2011,161(2):329-337.e1-2.
[25].Abraham WT,Nademanee K,Volosin K,et al. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure[J]. J Card Fail,2011,17(9):710-717.
[26].Kuschyk J,Roeger S,Schneider R,et al. Efficacy and survival in patients with cardiac contractility modulation:long-term single center experience in 81 patients[J]. Int J Cardiol,2015,183:76-81.
[27].Liu M,Fang F,Luo XX,et al. Improvement of long-term survival by cardiac contractility modulation in heart failure patients:a case-control study[J]. Int J Cardiol ,2016,206:122-126.
[28].R?ger S,Rudic B,Akin I,et al. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction[J]. Clin Cardiol,2018,41(4):518-524.
[29].Abraham WT,Kuck KH,Goldsmith RL,et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation[J]. JACC Heart Fail,2018,6(10):874-883.
[30].Anker SD,Borggrefe M,Neuser H,et al. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction[J]. Eur J Heart Fail,2019,21(9):1103-1113.
[31].Wiegn P,Chan R,Jost C,et al. Safety,performance,and efficacy of cardiac contractility modulation delivered by the 2-lead Optimizer S mart system:the FIX-HF-5C2 study[J]. Circ Heart Fail,2020,13(4):e006512.
[32].Kuschyk J,Falk P,Demming T,et al. Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system[J]. Eur J Heart Fail,2021,23(7):1160-1169.
[33].Fastner C,Yuecel G,Rudic B,et al. Cardiac contractility modulation in patients with ischemic versus non-ischemic cardiomyopathy:results from the MAINTAINED observational study[J]. Int J Cardiol,2021,342:49-55.
[34].Linde C,Grabowski M,Ponikowski P,et al. Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction:a pilot study(CCM-HFpEF)[J]. Eur J Heart Fail,2022,24(12):2275-2284.
[35].Dulai R,Chilmeran A,Hassan M,et al. How many patients with heart failure are eligible for cardiac contractility modulation therapy?[J].?Int J Clin Pract,2021,75(1):e13646.
[36].中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会. 植入型心律转复除颤器临床应用中国专家共识(2021)[J] . 中华心律失常学杂志,2021,25(4):280-299.
[37].R?ger S,Schneider R,Rudic B,et al. Cardiac contractility modulation:first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation[J]. Europace,2014,16(8):1205-1209.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(9):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(9):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(9):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(9):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(9):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(9):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(9):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]